More Info

General Info
Dr. Peshekâ??s background and experience in TMS dates back to June of 2004. After completing his Psychiatry Residency at The University of Pennsylvania, he accepted a fellowship position in Mood & Anxiety Disorders at U Penn, where he worked on clinical trials in Neuromodulation, including the FDA-pivotal trial for TMS. Spark TMS was opened in October of 2018. Transcranial Magnetic Stimulation was FDA-Approved in 2008 for treatment of major depression, 2013 for migraine and 2018 for OCD. The TMS protocol offered at Spark TMS is established for the patient under the direct supervision of Andrew Peshek, M.D.
Categories

Reviews

Hi there!
Be the first to review!
What do you rate this business?First-classBetter than mostAbout what I expectedNot the worst...Disappointing
Click to Rate

Details

Phone: (267) 713-3747

Address: 128 Chestnut St, Philadelphia, PA 19106

Website: website

People Also Viewed